Xilio Therapeutics, Inc. Quarterly Current Ratio in % from Q2 2022 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Xilio Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q2 2022 to Q3 2024.
  • Xilio Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2024 was 208 %, a 59.7% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 208 -308 -59.7% Sep 30, 2024
Q2 2024 252 -376 -59.9% Jun 30, 2024
Q1 2024 322 -410 -56% Mar 31, 2024
Q4 2023 441 -458 -51% Dec 31, 2023
Q3 2023 517 -639 -55.3% Sep 30, 2023
Q2 2023 628 -544 -46.4% Jun 30, 2023
Q1 2023 732 Mar 31, 2023
Q4 2022 899 Dec 31, 2022
Q3 2022 1.16K Sep 30, 2022
Q2 2022 1.17K Jun 30, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.